Japan Tobacco on Thursday reported a 9.7 per cent increase in annual adjusted operating profit from its tobacco business, ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Japan Tobacco on Thursday reported a 9.7% increase in annual adjusted operating profit, thanks to selling more higher-priced ...

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...